Assignee
CHEMGENES CORP
US·14 granted patents·2 pending applications·675 citations·filing 1991–2021
Top patents by PatentIndex Score
16 records- 0195US6015886AOligonucleotide phosphate estersCHEMGENES CORP·Filed 1997·Granted Jan 18, 2000·394 cites·14 claims
- 0291US7956169B1Synthesis of novel azo-dyes and their use in oligonucleotide synthesisCHEMGENES CORP·Filed 2010·Granted Jun 7, 2011·9 cites·24 claims
- 0389US5214135AN-protected-2'-O-methyl-ribonucleosides and N-protected 2'-O-methyl-3'-cyanoethyl-N-,N-diisopropyl phosphoramidite ribonucleosidesCHEMGENES CORP·Filed 1991·Granted May 25, 1993·117 cites·3 claims
- 0482US11634762B2RT-qPCR molecular detection and diagnosisCHEMGENES CORP·Filed 2020·Granted Apr 25, 2023·1 cites·26 claims
- 0580US5525719AN-protected-2'-O-methyl-and N-protected-3'-O-methyl-ribonucleosides and their phosphoramidite derivativesCHEMGENES CORP·Filed 1993·Granted Jun 11, 1996·84 cites·5 claims
- 0679US5744595APropargyl modified nucleosides and nucleotidesCHEMGENES CORP·Filed 1995·Granted Apr 28, 1998·60 cites·8 claims
- 0774US8933214B2RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-endCHEMGENES CORP·Filed 2012·Granted Jan 13, 2015·4 cites·3 claims
- 0868US7846436B2Oligonucleotides and related compoundsCHEMGENES CORP·Filed 2004·Granted Dec 7, 2010·6 cites·40 claims
- 0959US9718855B2Nucleosides and oligonucleotides for studies on reversal of cytotoxic and mutagenic damage of DNA and as diagnostics toolsCHEMGENES CORP·Filed 2014·Granted Aug 1, 2017·0 cites·1 claims
- 1057US9605261B2RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-endCHEMGENES CORP·Filed 2014·Granted Mar 28, 2017·0 cites·3 claims
- 1155US2021347645A1Macroporous Controlled Porosity Silica Gel Suitable For Oligonucleotide SynthesisCHEMGENES CORP·Filed 2021·Application pending·0 cites
- 1254US7932287B2Therapeutic compositions and usesCHEMGENES CORP·Filed 2005·Granted Apr 26, 2011·0 cites·5 claims
- 1354US2018066009A1Nucleosides and Oligonucleotides for Studies on Reversal of Cytotoxic and Mutagenic Damage of DNA and as Diagnostics ToolsCHEMGENES CORP·Filed 2017·Application pending·0 cites
- 1444US9969764B2Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfacesCHEMGENES CORP·Filed 2016·Granted May 15, 2018·0 cites·14 claims
- 1543US9441002B2Dithiolane based thiol modifier for labeling and stronger immobilization of bio-molecules on solid surfacesCHEMGENES CORP·Filed 2013·Granted Sep 13, 2016·0 cites·4 claims
- 1637US10167308B2Highly efficient synthesis of long RNA using reverse direction approachCHEMGENES CORP·Filed 2016·Granted Jan 1, 2019·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when CHEMGENES CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →